1. | raptorsfamily | |
2. | beastkingwarrior | |
3. | inlove4504 | |
4. | lilydale344 | |
5. | torralballac |
1. | raptorsfamily | |
2. | beastkingwarrior | |
3. | inlove4504 | |
4. | lilydale344 | |
5. | torralballac |
1. | inlove4504 03/30/2018 InspireMD, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock |
2. | beastkingwarrior 02/21/2018 InspireMD Announces Commercial Launch and First Sales of CGuard™ EPS in India |
3. | beastkingwarrior 01/22/2018 More good news - InspireMD Announces Publication of an Independent Imaging Study Highlighting the Advantages of CGuard EPS Compared to Another Next Generation Carotid Stent |
4. | beastkingwarrior 02/08/2018 InspireMD Announces 1-for-35 Reverse Stock Split |
5. | inlove4504 03/27/2018 I agree. |
6. | raptorsfamily 03/30/2018 This should be good once they reorganize |
7. | raptorsfamily 01/10/2018 InspireMD Projects 211% Increase in CGuard(TM) EPS Sales for the Fourth Quarter of 2017 |
8. | raptorsfamily 01/19/2018 Let's go |
9. | lilydale344 04/03/2018 InspireMD Anticipates Fifth Consecutive Quarter of Sequential Double Digit Growth; Projects 132% Increase in CGuard EPS Sales for the First Quarter of 2018; Total Quarterly Company Sales to Exceed $1 |
10. | raptorsfamily 01/03/2018 InspireMD Announces Regulatory Approval of CGuard EPS in India; Signs Agreement with Leading Indian Medical Device Distributor |